I-Oclacitinib maleate 1208319-27-0 Anti-inflammatory NSAID
Intlawulo:T/T, L/C
Imvelaphi yeMveliso:eTshayina
Indawo yokuthumela ngenqanawa:Beijing/Shanghai/Hangzhou
Iodolo (MOQ):10g
Ixesha lokukhokhela:3 iintsuku zokusebenza
Umthamo wemveliso:5kg/ngenyanga
Imeko yokugcina:Igcinwe kwindawo epholileyo, eyomileyo, ubushushu begumbi.
Ipakethe imathiriyeli:ingqayi
Ubungakanani bepakethi:10g/ibhodlela
Ulwazi ngokhuseleko:Ayizompahla eziyingozi
Intshayelelo
I-Oclacitinib, iyeza lonyango lwezilwanyana elisetyenziselwa ukulawula i-atopic dermatitis kunye ne-pruritus evela kwi-allergic dermatitis kwizinja ubuncinane kwiinyanga ezili-12 ubudala.I-Chemical, i-synthetic cyclohexylamino pyrrolopyrimidine janus kinase inhibitor ekhethiweyo ngokufanelekileyo kwi-JAK1.Ivimbela ukuhanjiswa kwesignali xa i-JAK ivuliwe kwaye ngaloo ndlela inceda ukunciphisa ukubonakaliswa kwee-cytokines ezivuthayo.
I-Oclacitinib ibhalwe ukunyanga i-atopic dermatitis kunye nokurhawuzelela (i-pruritus) okubangelwa kukwaliwa kwizinja, nangona ikwasetyenziselwe ukunciphisa ukurhawuzelela kunye ne-dermatitis ebangelwa ziinfestations zentakumba.Ithathwa njengesebenza kakhulu kwizinja, kwaye iye yasekwa njengekhuselekile ukusetyenziswa kwexesha elifutshane.
Inkcazo (kwimigangatho yendlu)
| Into | Inkcazo |
| Imbonakalo | Okumhlophe okuqinileyo |
| HNMR | Ukuthobela isakhiwo |
| I-LC-MS | Ukuthobela isakhiwo |
| Ubunyulu | ≥98% |
| Indawo yokunyibilika | N / A |
